Effect of comorbidity on lung cancer diagnosis timing and mortality: A nationwide population-based cohort study in Taiwan

Shinechimeg Dima, Kun Huang Chen, Kung Jeng Wang, Kung Min Wang, Nai Chia Teng

研究成果: 雜誌貢獻文章

1 引文 (Scopus)

摘要

The effect of comorbidity on lung cancer patients' survival has been widely reported. The aim of this study was to investigate the effects of comorbidity on the establishment of the diagnosis of lung cancer and survival in lung cancer patients in Taiwan by using a nationwide population-based study design. This study collected various comorbidity patients and analyzed data regarding the lung cancer diagnosis and survival during a 16-year follow-up period (1995-2010). In total, 101,776 lung cancer patients were included, comprising 44,770 with and 57,006 without comorbidity. The Kaplan-Meier analyses were used to compare overall survival between lung cancer patients with and without comorbidity. In our cohort, chronic bronchitis patients who developed lung cancer had the lowest overall survival in one (45%), five (28.6%), and ten years (26.2%) since lung cancer diagnosis. Among lung cancer patients with nonpulmonary comorbidities, patients with hypertension had the lowest overall survival in one (47.9%), five (30.5%), and ten (28.2%) years since lung cancer diagnosis. In 2010, patients with and without comorbidity had 14.86 and 9.31 clinical visits, respectively. Lung cancer patients with preexisting comorbidity had higher frequency of physician visits. The presence of comorbid conditions was associated with early diagnosis of lung cancer.
原文英語
文章編號1252897
期刊BioMed Research International
2018
DOIs
出版狀態已發佈 - 一月 1 2018

指紋

Taiwan
Comorbidity
Lung Neoplasms
Cohort Studies
Mortality
Population
Survival
Chronic Bronchitis
Kaplan-Meier Estimate
Early Detection of Cancer
Hypertension
Physicians

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

引用此文

Effect of comorbidity on lung cancer diagnosis timing and mortality : A nationwide population-based cohort study in Taiwan. / Dima, Shinechimeg; Chen, Kun Huang; Wang, Kung Jeng; Wang, Kung Min; Teng, Nai Chia.

於: BioMed Research International, 卷 2018, 1252897, 01.01.2018.

研究成果: 雜誌貢獻文章

@article{9c1e9583f02147a8be6159b40241ccb8,
title = "Effect of comorbidity on lung cancer diagnosis timing and mortality: A nationwide population-based cohort study in Taiwan",
abstract = "The effect of comorbidity on lung cancer patients' survival has been widely reported. The aim of this study was to investigate the effects of comorbidity on the establishment of the diagnosis of lung cancer and survival in lung cancer patients in Taiwan by using a nationwide population-based study design. This study collected various comorbidity patients and analyzed data regarding the lung cancer diagnosis and survival during a 16-year follow-up period (1995-2010). In total, 101,776 lung cancer patients were included, comprising 44,770 with and 57,006 without comorbidity. The Kaplan-Meier analyses were used to compare overall survival between lung cancer patients with and without comorbidity. In our cohort, chronic bronchitis patients who developed lung cancer had the lowest overall survival in one (45{\%}), five (28.6{\%}), and ten years (26.2{\%}) since lung cancer diagnosis. Among lung cancer patients with nonpulmonary comorbidities, patients with hypertension had the lowest overall survival in one (47.9{\%}), five (30.5{\%}), and ten (28.2{\%}) years since lung cancer diagnosis. In 2010, patients with and without comorbidity had 14.86 and 9.31 clinical visits, respectively. Lung cancer patients with preexisting comorbidity had higher frequency of physician visits. The presence of comorbid conditions was associated with early diagnosis of lung cancer.",
author = "Shinechimeg Dima and Chen, {Kun Huang} and Wang, {Kung Jeng} and Wang, {Kung Min} and Teng, {Nai Chia}",
year = "2018",
month = "1",
day = "1",
doi = "10.1155/2018/1252897",
language = "English",
volume = "2018",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Effect of comorbidity on lung cancer diagnosis timing and mortality

T2 - A nationwide population-based cohort study in Taiwan

AU - Dima, Shinechimeg

AU - Chen, Kun Huang

AU - Wang, Kung Jeng

AU - Wang, Kung Min

AU - Teng, Nai Chia

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The effect of comorbidity on lung cancer patients' survival has been widely reported. The aim of this study was to investigate the effects of comorbidity on the establishment of the diagnosis of lung cancer and survival in lung cancer patients in Taiwan by using a nationwide population-based study design. This study collected various comorbidity patients and analyzed data regarding the lung cancer diagnosis and survival during a 16-year follow-up period (1995-2010). In total, 101,776 lung cancer patients were included, comprising 44,770 with and 57,006 without comorbidity. The Kaplan-Meier analyses were used to compare overall survival between lung cancer patients with and without comorbidity. In our cohort, chronic bronchitis patients who developed lung cancer had the lowest overall survival in one (45%), five (28.6%), and ten years (26.2%) since lung cancer diagnosis. Among lung cancer patients with nonpulmonary comorbidities, patients with hypertension had the lowest overall survival in one (47.9%), five (30.5%), and ten (28.2%) years since lung cancer diagnosis. In 2010, patients with and without comorbidity had 14.86 and 9.31 clinical visits, respectively. Lung cancer patients with preexisting comorbidity had higher frequency of physician visits. The presence of comorbid conditions was associated with early diagnosis of lung cancer.

AB - The effect of comorbidity on lung cancer patients' survival has been widely reported. The aim of this study was to investigate the effects of comorbidity on the establishment of the diagnosis of lung cancer and survival in lung cancer patients in Taiwan by using a nationwide population-based study design. This study collected various comorbidity patients and analyzed data regarding the lung cancer diagnosis and survival during a 16-year follow-up period (1995-2010). In total, 101,776 lung cancer patients were included, comprising 44,770 with and 57,006 without comorbidity. The Kaplan-Meier analyses were used to compare overall survival between lung cancer patients with and without comorbidity. In our cohort, chronic bronchitis patients who developed lung cancer had the lowest overall survival in one (45%), five (28.6%), and ten years (26.2%) since lung cancer diagnosis. Among lung cancer patients with nonpulmonary comorbidities, patients with hypertension had the lowest overall survival in one (47.9%), five (30.5%), and ten (28.2%) years since lung cancer diagnosis. In 2010, patients with and without comorbidity had 14.86 and 9.31 clinical visits, respectively. Lung cancer patients with preexisting comorbidity had higher frequency of physician visits. The presence of comorbid conditions was associated with early diagnosis of lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=85057133266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057133266&partnerID=8YFLogxK

U2 - 10.1155/2018/1252897

DO - 10.1155/2018/1252897

M3 - Article

AN - SCOPUS:85057133266

VL - 2018

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 1252897

ER -